1.01 USD
-0.05 (-4.72%)
ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.87. This target is -14.16% below the current price.
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-08-11 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-05-20 | Ascendiant Capital | Maintains | Buy |
NOVABAY PHARMACEUTICALS INC / NBY FAQ
Can you provide the average price target for NOVABAY PHARMACEUTICALS INC stock?
5 analysts have analysed NBY and the average price target is 0.87 USD. This implies a price decrease of -14.16% is expected in the next year compared to the current price of 1.01.
Can you provide the consensus rating for NOVABAY PHARMACEUTICALS INC stock?
The consensus rating for NOVABAY PHARMACEUTICALS INC (NBY) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for NOVABAY PHARMACEUTICALS INC stock?
The number of analysts covering NOVABAY PHARMACEUTICALS INC (NBY) is 5.